Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Mirati Therapeutics

Mirati Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.

Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Amgen AMGN:US USD 60.76B 23.41B
Astellas Pharma 4503:JP JPY 139.92B 8.81B
AstraZeneca AZN:LN USD 27.65B 3.96B
Bayer BAYN:GR EUR 33.57B 220M
Eisai 4523:JP JPY 84.9B 16M
Eli Lilly LLY:US USD 18.88B 4.14B
GlaxoSmithKline GSK:LN GBP 16.64B 391M
Incyte Corp INCY:US USD 29.7M 384K
Ionis Pharmaceuticals IONS:US USD 1.18B 1.66M
J&J JNJ:US USD 34.93B 8.04B
Moderna Inc MRNA:US USD 831M 81M
Novartis NOVN:VX USD 21.99B 203M
Puma Biotechnology PBYI:US USD 98.62M 316K
Roche Holding ROG:VX CHF 21.39B 978M
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
Spectrum Pharmaceuticals SPPI:US USD 28.84M 174K
Takeda 4502:JP JPY 4.04T 127.86B